Form 4: Interpace Biosciences CFO Receives Stock Grant
Insider Transaction (Form 4)
Christopher Mccarthy, CFO & COO of Interpace Biosciences, Inc., reported multiple transactions in common stock on August 20, 2026.
Summary
- Option exercise/conversion: acquired 277,009 Common Stock on August 20, 2026; holds 323,800 after (Direct).
- Grant/award: acquired 554,018 Restricted Stock Units on August 20, 2026; holds 554,018 after (Direct).
- Option exercise/conversion: disposed of 277,009 Restricted Stock Units on August 20, 2026; holds 277,009 after (Direct).
- Grant/award: acquired 277,009 Stock Option (right to buy) on August 20, 2026; holds 277,009 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Christopher Mccarthy — Officer (CFO & COO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Option exercise/conversion | Common Stock | 277,009 | — | — | 323,800 |
| 2026-08-20 | Grant/award | Restricted Stock Units | 554,018 | — | — | 554,018 |
| 2026-08-20 | Option exercise/conversion | Restricted Stock Units | 277,009 | — | — | 277,009 |
| 2026-08-20 | Grant/award | Stock Option (right to buy) | 277,009 | — | — | 277,009 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Option exercise/conversion (277,009 shares) |
| 2026-08-20 | Grant/award (554,018 shares) |
| 2026-08-20 | Option exercise/conversion (277,009 shares) |
| 2026-08-20 | Grant/award (277,009 shares) |
Keywords
insider transaction, Form 4, IDXG, INTERPACE BIOSCIENCES, INC., neutral, Christopher Mccarthy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.